The/DT
position/NN
of/IN
the/DT
ZEBRA/NN
activation/NN
domain/NN
does/VBZ
not/RB
influence/VB
its/PRP$
biological/JJ
activity/NN
./.

Epstein-Barr/JJ
virus/NN
(/(
EBV/NN
)/)
is/VBZ
a/DT
human/JJ
herpesvirus/NN
which/WDT
latently/RB
infects/VBZ
B/NN
lymphocytes/NNS
./.
=====
EBV/NN
encodes/VBZ
a/DT
unique/JJ
transcriptional/JJ
activator/NN
,/,
known/VBN
as/IN
ZEBRA/NN
,/,
which/WDT
can/MD
disrupt/VB
viral/JJ
latency/NN
in/IN
B/NN
cells/NNS
and/CC
induce/VB
lytic/JJ
viral/JJ
replication/NN
./.
=====
Furthermore/RB
,/,
ZEBRA/NN
has/VBZ
been/VBN
shown/VBN
to/TO
bind/VB
at/IN
the/DT
EBV/NN
origin/NN
of/IN
lytic/JJ
replication/NN
,/,
and/CC
is/VBZ
necessary/JJ
for/IN
viral/JJ
DNA/NN
replication/NN
to/TO
occur/VB
./.
=====
Previously/RB
we/PRP
demonstrated/VBD
that/IN
heterologous/JJ
activation/NN
domains/NNS
can/MD
fully/RB
substitute/VB
for/IN
the/DT
ZEBRA/NN
activation/NN
domain/NN
./.
=====
Here/RB
we/PRP
extend/VBP
those/DT
results/NNS
by/IN
showing/VBG
that/IN
the/DT
position/NN
of/IN
the/DT
ZEBRA/NN
activation/NN
domain/NN
or/CC
a/DT
heterologous/JJ
replacement/NN
domain/NN
does/VBZ
not/RB
influence/VB
its/PRP$
ability/NN
to/TO
function/VB
in/IN
the/DT
disruption/NN
of/IN
EBV/NN
latency/NN
./.
=====
In/IN
this/DT
study/NN
three/CD
novel/JJ
clones/NNS
were/VBD
constructed/VBN
in/IN
which/WDT
the/DT
ZEBRA/NN
activation/NN
region/NN
was/VBD
repositioned/VBN
to/TO
the/DT
carboxy/NN
terminus/NN
of/IN
the/DT
protein/NN
./.
=====
These/DT
mutants/NNS
were/VBD
used/VBN
to/TO
demonstrate/VB
that/IN
the/DT
ability/NN
of/IN
ZEBRA/NN
's/POS
wild/JJ
type/NN
domain/NN
to/TO
function/VB
in/IN
the/DT
complex/JJ
biological/JJ
process/NN
of/IN
virus/NN
activation/NN
is/VBZ
not/RB
compromised/VBN
by/IN
altering/VBG
its/PRP$
position/NN
within/IN
the/DT
protein/NN
./.